OS Therapies Inc
Clinical-stage immunotherapy company developing treatments for HER2-positive cancers.
OSTX | US
Overview
Corporate Details
- ISIN(s):
- US68764Y2072
- LEI:
- Country:
- United States of America
- Address:
- 15825 SHADY GROVE ROAD, 20850 ROCKVILLE
- Website:
- https://ostherapies.com/
Description
OS Therapies Inc. is a clinical-stage cancer immunotherapy company focused on developing treatments for cancers that express the HER2 protein. The company's approach is to activate the patient's immune system to target and destroy tumor cells. Its lead candidate, OST-HER2, is a therapeutic vaccine initially being developed for osteosarcoma, a type of bone cancer with a significant unmet medical need. The company plans to expand the development of its technology to other HER2-positive solid tumors, including breast, colorectal, esophageal, lung, and ovarian cancers. The pipeline also includes proprietary technologies like OST-tADC Tunable Drug Conjugates.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all OS Therapies Inc filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for OS Therapies Inc
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for OS Therapies Inc via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
